Chlamydia antibody testing in subfertile women.

Area of Science:

• Reproductive Health
• Infectious Diseases
• Gynecology

Background:

• Chlamydia trachomatis infections are frequently asymptomatic in women.
• Untreated infections can lead to tubal factor subfertility.
• Current screening methods for subfertility have limitations.

Purpose of the Study:

• To evaluate the diagnostic accuracy of C. trachomatis IgG antibody testing for tubal factor subfertility.
• To identify markers of persistent Chlamydia trachomatis infections associated with increased risk of tubal pathology.
• To assess the predictive value of combined infection markers in subfertile women.

Main Methods:

• Serological testing for C. trachomatis IgG antibodies to indicate past infection.
• Measurement of C-reactive protein levels as a marker for persistent infection.
• Correlation analysis between infection markers and the presence of tubal pathology in subfertile women.

Main Results:

• C. trachomatis IgG antibodies indicate a history of infection.
• Elevated C-reactive protein within the normal range suggests a persistent infection.
• Subfertile women with both C. trachomatis IgG antibodies and elevated C-reactive protein showed the highest risk for tubal pathology.

Conclusions:

• C. trachomatis IgG antibody testing alone has limited diagnostic accuracy for tubal factor subfertility.
• Combined markers of previous (IgG antibodies) and persistent (C-reactive protein) Chlamydia trachomatis infections improve risk prediction for tubal pathology.
• Identifying persistent infections is crucial for managing subfertility risk.